MAPT and early-onset autosomal dominant Alzheimer disease: To show the utility of this approach in finding useful fluoroprobes, we validated one hit molecule for histological staining of tau deposits in ex vivo brain slices from a transgenic mouse model of tauopathy and post-mortem samples from patients with Alzheimer’s disease.